West-MEC, a career and technical education public school district, is looking to pass a bond measure this fall to build a new ...

Alex Morey, vice president of campus advocacy at the Foundation for Individual Rights and Expression, a free speech group, said her group was monitoring orders like the one at West Point to see if ...

The U.S. Military Academy at West Point, N.Y., has ordered a dozen cadet extracurricular and social clubs to immediately and permanently “cease all activities,” with all affected groups ...

For the recently completed fourth quarter, Merck booked an adjusted profit of $1.72 per share on $15.6 billion in revenue. Sales of top-selling cancer treatment Keytruda climbed 19% to $7.84 billion.

FILE - West Point cadets salute during the National Anthem prior to the NCAA college football game between the Army Black Knights and Massachusetts at Michie Stadium, Saturday, Nov. 20 ...

Why Merck (MRK) Stock Is Falling Today What Happened? Shares of global pharmaceutical company Merck (NYSE:MRK) fell 11% in the morning session after the company reported mixed fourth-quarter earnings.

Merck’s Q4 sales rose 7% YoY to $15.62B, slightly beating the $15.49B consensus. Adjusted EPS jumped to $1.72, topping estimates of $1.62. Keytruda sales grew 19% YoY to $7.84B, while Gardasil ...

This rendering shows an aerial view of Vanderbilt University’s proposed West Palm Beach campus. (Vanderbilt University/Courtesy) Now, Vanderbilt has embarked on a campaign to raise $300 million ...

Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year. Despite strong performances from other pharmaceutical giants like Eli ...

Merck reported Q4 sales of $15.62 billion, up 7% YoY, exceeding the $15.49 billion estimate. Goldman Sachs raises Merck's price target to $135, citing growth potential. Get real-time earnings ...

Vanderbilt University has plans for two new campuses in West Palm Beach, Fla., and New York City. The $520 million Florida campus will focus on tech and business graduate programs with space for ...

Shares of Merck slid Tuesday after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales forecast due partly to a pause in shipments of one of its top-selling products to China.